Edoardo Pronello
Turin, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Long-Term Outcome of Molecularly Defined Oligodendrogliomas: Comparison of Grade 2 and 3 Tumors.
Journal: Neurology
Published: June 16, 2026
Rare gliomas: standard treatment approaches and new target therapies.
Journal: Current opinion in neurology
Published: September 24, 2025
Low-grade IDH-mutant gliomas: from standard post-surgical treatments to novel IDH inhibitors.
Journal: Expert opinion on pharmacotherapy
Published: June 06, 2025
Early seizure freedom with [18F]fluorodopa positron emission tomography response after isocitrate dehydrogenase inhibition with vorasidenib: First case report.
Journal: Epilepsia
Published: May 02, 2025
Education paths in neuro-oncology: combining technical skills with multidisciplinary care. A survey from the AINO (Italian Association for Neuro-Oncology) Youngster Committee.
Journal: Journal of neuro-oncology
Published: January 13, 2025
Association of Clinical, Tumor, and Treatment Characteristics With Seizure Control in Patients With IDH1/2-Mutant Lower-Grade Glioma.
Journal: Neurology
Published: April 29, 2024
Correction to: A systematic review of immunotherapy in high‑grade glioma: learning from the past to shape future perspectives.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: February 21, 2024
The early recognition and diagnosis of neoplastic meningitis.
Journal: Expert review of neurotherapeutics
Published: December 25, 2023
A systematic review of immunotherapy in high-grade glioma: learning from the past to shape future perspectives.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: November 28, 2023
Cerebral nocardiosis mimicking disseminated tumor lesions in a patient with recurrent glioblastoma.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: December 09, 2022
Observational real-life study on regorafenib in recurrent glioblastoma: does dose reduction reduce toxicity while maintaining the efficacy?
Journal: Journal of neuro-oncology
Published: September 05, 2022
Last Updated: 09/26/2026